Avanos Medical, Inc. (NYSE: AVNS) and American Industrial Partners announced on July 2, 2026, that they have received all required regulatory approvals to complete the pending acquisition of the Alpharetta, Georgia-based company by affiliates of American Industrial Partners. The joint announcement from Alpharetta and New York removes the last major institutional condition standing between the two companies and a completed deal. For shareholders and deal watchers, regulatory clearance is the threshold that transforms a pending transaction into a closing-track one.
What Regulatory Approval Means for a Merger
In any acquisition, the deal cannot close the moment it is signed. Government and regulatory bodies must first review whether the combination raises concerns — and both companies must satisfy every applicable jurisdiction before ownership formally transfers or operations begin to integrate. The phrase "all required regulatory approvals," used by both Avanos and American Industrial Partners in their joint statement, signals that no outstanding agency reviews remain as a condition to closing. Until a deal reaches this point, the target company continues to operate as a standalone entity, separate from its prospective buyer regardless of what either party intends.
The Parties and the Deal Structure
Avanos Medical trades on the New York Stock Exchange under the ticker AVNS and is headquartered in Alpharetta, Georgia. American Industrial Partners, based in New York, is the acquiring party; the transaction is structured specifically as an acquisition by affiliates of American Industrial Partners rather than the firm directly. That affiliate structure — where a fund vehicle rather than the parent organization serves as the purchasing entity — is a common feature of investment firm acquisitions.
What Remains Before the Deal Closes
With regulatory approvals in hand, the path to closing narrows to remaining contractual and administrative steps. Neither Avanos nor American Industrial Partners disclosed financial terms or a target closing date in the announcement. Investors in AVNS will be watching for a formal closing notice, which would mark Avanos Medical's transition from a publicly traded company to a privately held one under American Industrial Partners' ownership.